Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Eric D. ShaffDirector | -259,00 | 1,95k | Derivative Exercise and Sale | 7,53 | 12,04k | - |
| 2026-05-15 | Mr. Eric D. ShaffDirector | 463,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,04k | 4,00% |
| 2026-05-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -77,00 | 579,81 | Derivative Exercise and Sale | 7,53 | 7,84k | - |
| 2026-05-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 161,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,84k | 2,10% |
| 2026-05-15 | Ms. Kelly BradyExec. VP & COO | -59,00 | 444,27 | Derivative Exercise and Sale | 7,53 | 8,56k | - |
| 2026-05-15 | Ms. Kelly BradyExec. VP & COO | 121,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,56k | 1,43% |
| 2026-05-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -79,00 | 594,87 | Derivative Exercise and Sale | 7,53 | 7,95k | - |
| 2026-05-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 165,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,95k | 2,12% |
| 2026-02-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 166,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,79k | 2,18% |
| 2026-02-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -78,00 | 660,66 | Derivative Exercise and Sale | 8,47 | 7,79k | - |
| 2026-02-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 150,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,68k | 1,99% |
| 2026-02-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -89,00 | 753,83 | Derivative Exercise and Sale | 8,47 | 7,68k | - |
| 2026-02-15 | Dr. Teresa L. YoungInsider | 156,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,56k | 1,86% |
| 2026-02-15 | Dr. Teresa L. YoungInsider | -75,00 | 635,25 | Derivative Exercise and Sale | 8,47 | 8,56k | - |
| 2026-02-15 | Mr. Eric D. ShaffDirector | 464,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,58k | 4,18% |
| 2026-02-15 | Mr. Eric D. ShaffDirector | -259,00 | 2,19k | Derivative Exercise and Sale | 8,47 | 11,58k | - |
| 2025-11-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -1,26k | 21,75k | Derivative Exercise and Sale | 17,30 | 7,53k | - |
| 2025-11-15 | Mr. Eric D. ShaffDirector | 504,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,11k | 4,75% |
| 2025-11-15 | Mr. Eric D. ShaffDirector | -217,00 | 3,75k | Derivative Exercise and Sale | 17,30 | 11,11k | - |
| 2025-11-15 | Dr. Teresa L. YoungInsider | 3,19k | 0,00 | Derivative Exercise and Retained Stock | - | 8,40k | 61,09% |
| 2025-11-15 | Dr. Teresa L. YoungInsider | -1,04k | 18,03k | Derivative Exercise and Sale | 17,30 | 8,40k | - |
| 2025-11-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 168,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,62k | 2,25% |
| 2025-11-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -76,00 | 1,31k | Derivative Exercise and Sale | 17,30 | 7,62k | - |
| 2025-11-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 2,98k | 0,00 | Derivative Exercise and Retained Stock | - | 7,53k | 65,50% |
| 2025-08-15 | Mr. Eric D. ShaffDirector | 507,00 | 0,00 | Derivative Exercise and Retained Stock | - | 10,61k | 5,02% |
| 2025-08-15 | Mr. Eric D. ShaffDirector | -217,00 | 3,61k | Derivative Exercise and Sale | 16,65 | 10,61k | - |
| 2025-08-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 168,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,46k | 2,31% |
| 2025-08-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -76,00 | 1,27k | Derivative Exercise and Sale | 16,65 | 7,46k | - |
| 2025-08-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 165,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,55k | 3,76% |
| 2025-08-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -73,00 | 1,22k | Derivative Exercise and Sale | 16,65 | 4,55k | - |
| 2025-08-15 | Dr. Teresa L. YoungInsider | 171,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,22k | 3,39% |
| 2025-08-15 | Dr. Teresa L. YoungInsider | -59,00 | 982,35 | Derivative Exercise and Sale | 16,65 | 5,22k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
